Clinical Trial Update: Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to misoprostol for high-risk postpartum hemorrhage after cesarean section; status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)
• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Beni-Suef University | Conditions: Postpartum Hemorrhage | Phase 4 | Status: UNKNOWN